The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates
Part of paid clinical trials in Huntington Beach, California.
- Sponsor
- South Coast Retina Center; Carson, McBeath, Boswell, Inc.
- Study ID
- NCT02448446
- Phase
- PHASE1/PHASE2
- Status
- Completed
Conditions
- Diabetic Macular Edema
- Hard Lipid Exudates
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- ranibizumab 0.3mg — DRUGintravitreally administered
Study Details
This is an open-label, Phase I/II study of intravitreally administered 0.3mg ranibizumab in subjects with diabetic macular edema and lipid exudates in the central subfield.
Key Dates
- First listed
- May 19, 2015
- Start date
- Aug 31, 2015
- Status verified
- Jul 2021
- Primary completion
- May 31, 2018
- Completion
- May 31, 2018
Study Design
- Enrollment
- 25 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Diabetic macular edema treatment group (Group 1)Treatment using intravitreal ranibizumab 0.3mg based on the DRCR protocol I 4:2:7 strategy based on the presence of macular edema.
- Active Comparator: Diabetic macular edema and lipid treatment group (Group 2)Continued treatment with intravitreal ranibizumab 0.3mg until, not only the macular edema is resolved, but also until the lipid exudate is resolved.
Primary Outcome Measure
Best Corrected Visual Acuity as Measured by ETDRS at 6 and 12 Months [ Time Frame: 6-12 months ]
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| South Coast Retina Center; Carson, McBeath, Boswell, Inc | Huntington Beach | California | 92647 | - |
| South Coast Retina Center; Carson, McBeath, and Boswell, Inc | Long Beach | California | 90505 | - |
| Retina Partners | Santa Monica | California | 90404 | - |
| South Coast Retina Center; Carson, McBeath, Boswell, Inc | Torrance | California | 90505 | - |
Find similar trials in Huntington Beach, CA
By condition
By specialty
Related Studies
- A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)PHASE1 · Recruiting · Genentech, Inc. · Peoria, Arizona
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEPHASE3 · Recruiting · EyePoint Pharmaceuticals, Inc. · Gilbert, Arizona
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEPHASE3 · Recruiting · EyePoint Pharmaceuticals, Inc. · Bakersfield, California
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are ToleratedPHASE1/PHASE2 · Recruiting · Boehringer Ingelheim · Phoenix, Arizona